Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 3 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Melanoma in children and adolescents: analysis of susceptibility genes in 123 Italian patients.
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):213-221. doi: 10.1111/jdv.17735. Epub 2021 Nov 3.
J Eur Acad Dermatol Venereol. 2022.
PMID: 34664323
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy.
Grottoli M, Carrega P, Zullo L, Dellepiane C, Rossi G, Parisi F, Barletta G, Zinoli L, Coco S, Alama A, Marconi S, Parodi M, Orecchia P, Bassi S, Vitale M, Mingari MC, Pfeffer U, Genova C, Pietra G.
Grottoli M, et al.
Cancers (Basel). 2022 Oct 14;14(20):5046. doi: 10.3390/cancers14205046.
Cancers (Basel). 2022.
PMID: 36291830
Free PMC article.
Review.
Item in Clipboard
Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants.
Spagnolo F, Dalmasso B, Tanda E, Potrony M, Puig S, van Doorn R, Kapiteijn E, Queirolo P, Helgadottir H, Ghiorzo P.
Spagnolo F, et al.
Cancers (Basel). 2021 May 18;13(10):2440. doi: 10.3390/cancers13102440.
Cancers (Basel). 2021.
PMID: 34069952
Free PMC article.
Item in Clipboard
HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAFV600E Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia.
Furfaro AL, Loi G, Ivaldo C, Passalacqua M, Pietra G, Mann GE, Nitti M.
Furfaro AL, et al.
Antioxidants (Basel). 2022 Jun 14;11(6):1171. doi: 10.3390/antiox11061171.
Antioxidants (Basel). 2022.
PMID: 35740068
Free PMC article.
Item in Clipboard
Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization.
Mastracci L, Fontana V, Queirolo P, Carosio R, Grillo F, Morabito A, Banelli B, Tanda E, Boutros A, Dozin B, Gualco M, Salvi S, Romani M, Spagnolo F, Poggi A, Pistillo MP.
Mastracci L, et al.
Cancer Immunol Immunother. 2020 Apr;69(4):653-662. doi: 10.1007/s00262-020-02494-y. Epub 2020 Feb 5.
Cancer Immunol Immunother. 2020.
PMID: 32025849
Free PMC article.
Item in Clipboard
Cite
Cite